Sisram Medical Ltd
HKEX:1696
Sisram Medical Ltd
HKEX:1696
Price:
4.02 HKD
7.77%
Updated:
May 10, 2024
Balance Sheet
Balance Sheet Decomposition
Sisram Medical Ltd
Sisram Medical Ltd
| Current Assets | 257.3m |
| Cash & Short-Term Investments | 70.6m |
| Receivables | 83.5m |
| Other Current Assets | 103.3m |
| Non-Current Assets | 356.2m |
| Long-Term Investments | 6.2m |
| PP&E | 62.9m |
| Intangibles | 263m |
| Other Non-Current Assets | 24.1m |
| Current Liabilities | 88.3m |
| Accounts Payable | 8m |
| Other Current Liabilities | 80.3m |
| Non-Current Liabilities | 72.9m |
| Long-Term Debt | 35.5m |
| Other Non-Current Liabilities | 37.4m |
Balance Sheet
Sisram Medical Ltd
Sisram Medical Ltd
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
18
|
19
|
18
|
38
|
34
|
100
|
83
|
125
|
75
|
71
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
71
|
|
| Cash Equivalents |
18
|
19
|
18
|
38
|
34
|
100
|
83
|
125
|
75
|
0
|
|
| Short-Term Investments |
19
|
20
|
24
|
66
|
71
|
8
|
33
|
28
|
7
|
0
|
|
| Total Receivables |
22
|
23
|
28
|
38
|
40
|
52
|
47
|
70
|
80
|
83
|
|
| Accounts Receivables |
22
|
23
|
28
|
35
|
36
|
49
|
47
|
70
|
80
|
83
|
|
| Other Receivables |
0
|
0
|
0
|
2
|
4
|
2
|
1
|
0
|
0
|
0
|
|
| Inventory |
18
|
22
|
22
|
24
|
28
|
33
|
37
|
64
|
75
|
81
|
|
| Other Current Assets |
2
|
2
|
3
|
1
|
3
|
4
|
4
|
11
|
14
|
23
|
|
| Total Current Assets |
80
|
86
|
95
|
166
|
175
|
197
|
205
|
298
|
251
|
257
|
|
| PP&E Net |
2
|
2
|
2
|
2
|
3
|
14
|
46
|
45
|
52
|
63
|
|
| PP&E Gross |
2
|
2
|
2
|
2
|
3
|
14
|
46
|
45
|
52
|
0
|
|
| Accumulated Depreciation |
1
|
2
|
2
|
3
|
4
|
5
|
6
|
8
|
11
|
0
|
|
| Intangible Assets |
77
|
72
|
67
|
64
|
59
|
59
|
53
|
51
|
45
|
136
|
|
| Goodwill |
108
|
108
|
108
|
108
|
108
|
111
|
111
|
111
|
111
|
127
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
7
|
11
|
13
|
13
|
13
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
6
|
6
|
|
| Other Long-Term Assets |
4
|
5
|
6
|
5
|
5
|
5
|
5
|
11
|
77
|
11
|
|
| Other Assets |
108
|
108
|
108
|
108
|
108
|
111
|
111
|
111
|
111
|
127
|
|
| Total Assets |
270
N/A
|
273
+1%
|
279
+2%
|
347
+24%
|
350
+1%
|
393
+12%
|
432
+10%
|
530
+23%
|
556
+5%
|
614
+10%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
7
|
7
|
7
|
7
|
7
|
12
|
9
|
13
|
13
|
8
|
|
| Accrued Liabilities |
9
|
7
|
12
|
13
|
12
|
16
|
20
|
40
|
40
|
0
|
|
| Short-Term Debt |
0
|
0
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
9
|
10
|
12
|
4
|
2
|
5
|
4
|
10
|
9
|
9
|
|
| Other Current Liabilities |
5
|
17
|
6
|
10
|
3
|
6
|
21
|
21
|
19
|
71
|
|
| Total Current Liabilities |
29
|
41
|
47
|
35
|
24
|
39
|
55
|
84
|
80
|
88
|
|
| Long-Term Debt |
59
|
49
|
37
|
7
|
0
|
7
|
33
|
31
|
33
|
36
|
|
| Deferred Income Tax |
13
|
12
|
13
|
11
|
10
|
11
|
10
|
9
|
9
|
14
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
17
|
|
| Other Liabilities |
144
|
138
|
142
|
2
|
2
|
10
|
2
|
2
|
2
|
6
|
|
| Total Liabilities |
245
N/A
|
240
-2%
|
239
-1%
|
54
-78%
|
36
-33%
|
67
+87%
|
100
+49%
|
128
+28%
|
125
-3%
|
161
+29%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
24
|
32
|
40
|
51
|
73
|
84
|
88
|
80
|
113
|
451
|
|
| Additional Paid In Capital |
1
|
1
|
1
|
241
|
241
|
241
|
241
|
320
|
322
|
0
|
|
| Other Equity |
0
|
0
|
1
|
0
|
1
|
1
|
1
|
1
|
5
|
0
|
|
| Total Equity |
25
N/A
|
33
+30%
|
40
+24%
|
293
+624%
|
314
+7%
|
326
+4%
|
332
+2%
|
402
+21%
|
431
+7%
|
452
+5%
|
|
| Total Liabilities & Equity |
270
N/A
|
273
+1%
|
279
+2%
|
347
+24%
|
350
+1%
|
393
+12%
|
432
+10%
|
530
+23%
|
556
+5%
|
614
+10%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
352
|
352
|
352
|
442
|
442
|
442
|
442
|
466
|
467
|
468
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
